Please use this identifier to cite or link to this item:
https://doi.org/10.1038/ncomms12983
Title: | Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity | Authors: | Ooi, W.F Xing, M Xu, C Yao, X Ramlee, M.K Lim, M.C Cao, F Lim, K Babu, D Poon, L.-F Lin Suling, J Qamra, A Irwanto, A Qu Zhengzhong, J Nandi, T Lee-Lim, A.P Chan, Y.S Tay, S.T Lee, M.H Davies, J.O.J Wong, W.K Soo, K.C Chan, W.H Ong, H.S Chow, P Wong, C.Y Rha, S.Y Liu, J Hillmer, A.M Hughes, J.R Rozen, S Teh, B.T Fullwood, M.J Li, S Tan, P |
Keywords: | hepatocyte nuclear factor 4alpha transcription factor Cdx2 cancer cells and cell components chromosome gene expression genetic analysis genomics heterogeneity mortality tumor Article cancer susceptibility cell interaction chromatin controlled study enhancer region epigenetics gene expression genetic heterogeneity genetic risk histone modification human human cell human tissue primary tumor single nucleotide polymorphism stomach adenocarcinoma |
Issue Date: | 2016 | Publisher: | Nature Publishing Group | Citation: | Ooi, W.F, Xing, M, Xu, C, Yao, X, Ramlee, M.K, Lim, M.C, Cao, F, Lim, K, Babu, D, Poon, L.-F, Lin Suling, J, Qamra, A, Irwanto, A, Qu Zhengzhong, J, Nandi, T, Lee-Lim, A.P, Chan, Y.S, Tay, S.T, Lee, M.H, Davies, J.O.J, Wong, W.K, Soo, K.C, Chan, W.H, Ong, H.S, Chow, P, Wong, C.Y, Rha, S.Y, Liu, J, Hillmer, A.M, Hughes, J.R, Rozen, S, Teh, B.T, Fullwood, M.J, Li, S, Tan, P (2016). Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity. Nature Communications 7 : 12983. ScholarBank@NUS Repository. https://doi.org/10.1038/ncomms12983 | Abstract: | Regulatory enhancer elements in solid tumours remain poorly characterized. Here we apply micro-scale chromatin profiling to survey the distal enhancer landscape of primary gastric adenocarcinoma (GC), a leading cause of global cancer mortality. Integrating 110 epigenomic profiles from primary GCs, normal gastric tissues and cell lines, we highlight 36,973 predicted enhancers and 3,759 predicted super-enhancers respectively. Cell-line-defined super-enhancers can be subclassified by their somatic alteration status into somatic gain, loss and unaltered categories, each displaying distinct epigenetic, transcriptional and pathway enrichments. Somatic gain super-enhancers are associated with complex chromatin interaction profiles, expression patterns correlated with patient outcome and dense co-occupancy of the transcription factors CDX2 and HNF4?. Somatic super-enhancers are also enriched in genetic risk SNPs associated with cancer predisposition. Our results reveal a genome-wide reprogramming of the GC enhancer and super-enhancer landscape during tumorigenesis, contributing to dysregulated local and regional cancer gene expression. © 2016 The Author(s). | Source Title: | Nature Communications | URI: | https://scholarbank.nus.edu.sg/handle/10635/174932 | ISSN: | 20411723 | DOI: | 10.1038/ncomms12983 |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1038_ncomms12983.pdf | 3.98 MB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.